Chuan-yuan Wei

Minhang Branch
Shanghai, 200240, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.

Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.

Journal: Molecular cancer
Published: February 29, 2024

Fabrication of near infrared light responsive photoelectrochemical immunosensor for in vivo detection of melanoma cells.

Fabrication of near infrared light responsive photoelectrochemical immunosensor for in vivo detection of melanoma cells.

Journal: Biosensors & bioelectronics
Published: June 04, 2023

Overcoming chemoresistance to b-raf inhibitor in melanoma via targeted inhibition of phosphoenolpyruvate carboxykinase1 using 3-mercaptopropionic acid.

Overcoming chemoresistance to b-raf inhibitor in melanoma via targeted inhibition of phosphoenolpyruvate carboxykinase1 using 3-mercaptopropionic acid.

Journal: Bioengineered
Published: January 26, 2023

Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.

Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.

Journal: Cancer letters
Published: January 05, 2023

Corrigendum to: "PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma" [J Hepatol 77 (2022) 163-176].

Corrigendum to: "PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma" [J Hepatol 77 (2022) 163-176].

Journal: Journal of hepatology
Published: December 23, 2022

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis.

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis.

Journal: Cell death & disease
Published: February 24, 2022

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma.

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma.

Journal: Journal of hepatology
Published: September 26, 2021

M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1/2, and STAT3 signaling pathways.

M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1/2, and STAT3 signaling pathways.

Journal: Molecular biology reports
Published: June 14, 2021

Integration of individual prediction index based on autophagy-related genes and clinical phenomes in melanoma patients.

Integration of individual prediction index based on autophagy-related genes and clinical phenomes in melanoma patients.

Journal: Clinical and translational medicine
Published: June 04, 2020

Hsa-let-7b Suppresses Cell Proliferation by Targeting UHRF1 in Melanoma.

Hsa-let-7b Suppresses Cell Proliferation by Targeting UHRF1 in Melanoma.

Journal: Cancer investigation
Published: December 25, 2019

Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma.

Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma.

Journal: Molecular cancer
Published: December 06, 2019

Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.

Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.

Journal: Molecular cancer
Published: November 29, 2019
Showing 1-12 of 25

Last Updated: 09/26/2026